MondayOct 29, 2018 11:19 am

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Announces Final Assay Results on Latest Flagship Site Exploration

Canada-based Marifil Mines is preparing to commission an NI 43-101 report by the end of the year on its Argentina exploration San Roque site has a total of 112 drill holes, all of which have intercepted some degree of mineralization Finalized assay reports indicate that San Roque site “continues to be a first class gold exploration project” Canadian metals explorer Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) has received the final assay results for diamond drill core-sampling test holes explored this summer at its flagship Argentina site in the Province of Rio Negro, known as the San Roque property, which…

Continue Reading

FridayOct 26, 2018 11:10 am

GreenBox POS, LLC (GRBX) Focuses on Increasing Transaction Volume Across its Blockchain-based Payment Solutions Platform

GRBX expects to ship enough new integrated hardware and software units to bring $750,000 in monthly net income by year-end GreenBox has a goal of processing $1 billion of transactional volume in FY2019 The company recently acquired Sky Mids Technologies, boosting its volume capacity GRBX is well positioned in multiple rapidly growing sectors, including payments processing, fintech and secure point of sale terminals Fresh off deployment of its latest blockchain-based hardware and software to payments solutions clients, GreenBox POS, LLC (OTC: GRBX) is focused on ramping up transaction volume. GreenBox plans to ship enough of its newest TrustGateway units pre-installed…

Continue Reading

FridayOct 26, 2018 10:51 am

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Closes Private Placement Financing, Engages Communications and Marketing Services

Marifil Mines recently closed a private placement financing Marifil has hired UnityWest Capital Markets to provide marketing services Canada One Communication has been engaged to provide Marifil’s investor relations Mining exploration company Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) has announced closings of multiple private placement financings, as well as the engagement of firms to provide marketing and investor relations services to the company. The Vancouver-based company is focused on exploration for cobalt, lithium and gold, as well as other metals, on its mining property holdings in Argentina. Marifil recently closed a non-brokered private placement with proceeds of C$565,000, with…

Continue Reading

FridayOct 26, 2018 10:29 am

Medical Cannabis Payment Solutions (REFG): A Cannabis Industry Pioneer

Medical Cannabis Payment Solutions serves the legal cannabis industry with an end-to-end payment processing solution The company serves medical and recreational-related businesses and dispensaries Its payment solution card is unique for purchasing cannabis-related products from state-sanctioned merchants Medical Cannabis Payment Solutions (OTC: REFG) is a first-tier merchant processing cannabis industry innovator. The company serves the legal cannabis industry with a premier end-to-end payment processing solution that is FinCEN (Financial Crimes Enforcement Network) compliant. Its proprietary payment system goes by the name ‘Green’. Medical Cannabis Payment Solutions is headquartered in Cheyenne, Wyoming. The company offers one of the first and only…

Continue Reading

FridayOct 26, 2018 10:06 am

CytoDyn Inc. (CYDY) to Complete Development of Prostate Cancer Prognostic Test Following Close of ProstaGene Acquisition

PCaTest has already proven a superior predictive ability in comparison with other genetic prognostic tests Cytodyn in the process of acquiring PCaTest developer ProstaGene and will launch a clinical study once the transaction is complete Prostate cancer is the second-most common type of cancer among American men, with almost 165,000 new cases expected this year Biotechnology company CytoDyn Inc. (OTCQB: CYDY) has unveiled a comprehensive strategy for the development of a genetic prostate cancer prognostic test (http://ibn.fm/GSEfb). Developed by ProstaGene, an entity that CytoDyn is in the process of acquiring, PCaTest has already demonstrated superior predictive ability in comparison to other…

Continue Reading

ThursdayOct 25, 2018 11:59 am

CytoDyn Inc. (CYDY) Finding Success in Trials of PRO 140 for Treatment of HIV/AIDS; Plans to Expand Clinical Investigations to Cancer

Lead product candidate, PRO 140, is a viral-entry inhibitor that works by blocking the entry of HIV/AIDS to healthy cells by masking CCR5 receptor Completion of Biological License Application (BLA) for potential approval in combination HIV therapy expected in Q1 2019 CytoDyn received approval to increase dosing of PRO 140 in its phase 3 adaptive clinical trial for enrolled HIV/AIDS patients Market potential for PRO 140 as an anti-viral agent in combination with HAART is $1.2 billion; as a monotherapy maintenance/single-drug therapy, the market is estimated at $3.8 billion Acquisition of privately held ProstaGene expected to complete in November, giving…

Continue Reading

ThursdayOct 25, 2018 11:41 am

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Encounters Lithium Brines in Additional Drill Holes, Confirming Geophysical Profile of Ollague Project

Drilling shows additional lithium-bearing brines carrying highly conductive zones, suggesting that lithium grades increase with depth Brines tested lithium grades starting at 150 mg/l, increasing to 270 mg/l when drill holes reached 250-meter contracted depth Results of recent drilling reinforce company’s decision to test deeper limits of aquifer Lithium Chile holds one of the largest lithium land holdings in Chile, a country with about 50 percent of the world’s reserves Global demand for lithium, which is vital to rechargeable batteries, is expected to increase by 650 percent by 2027 Mineral explorer Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) continues to…

Continue Reading

ThursdayOct 25, 2018 11:07 am

Cannabis Strategic Ventures, Inc. (NUGS) Welcomes PureOrganix Shelf Presence as Sign of Life in Growing Industry

Americans spending a growing amount of capital on cannabis concentrates, with forecasts for $2.9 billion in sales this year Cannabis Strategic Ventures recently announced the introduction of high-quality concentrate line PureOrganix in California dispensaries PureOrganix presence expected to gain national, international footing amid advancing tide of cannabis legalization Cannabis industry incubator Cannabis Strategic Ventures, Inc. (OTC: NUGS) is working its way toward a national stock exchange uplisting and growing its presence within the industry through a series of timely business building ventures, including the introduction of PureOrganix, a brand marketed by subsidiary Pure Applied Sciences as a California dispensary shelf…

Continue Reading

ThursdayOct 25, 2018 10:45 am

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Breast Cancer Therapy Trials to Patient Dosing Stage

Breast cancer is the leading cancer diagnosed in women and the second-most common cancer overall BriaCell Therapeutics has begun patient dosing in clinical trials that combine its trademarked Bria-IMT technology with celebrated cancer-fighting antibodies The clinical trials are working on a therapy that will help the body’s own immune system fight cancerous cells The battle against breast cancer is taking a technological turn amid an increasing drive to develop therapies that use the body’s own immune system to destroy life-threatening cancer cells. BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) is on the front line of the battle and is currently…

Continue Reading

WednesdayOct 24, 2018 11:51 am

Sharing Services, Inc. (SHRV) Sees Significant Increase in Sales in 2018

The sustainable financial growth that Sharing Services marked at the beginning of 2018 continued through the summer months Steady increase in both sales volume and assets reported The growth was accomplished through the execution of a strategic growth plan aimed at expanding Sharing Services’ range of products Diversified holding company Sharing Services, Inc. (OTCQB: SHRV) has seen a significant rise in sales over the past three quarters. As of July 2018, the company’s sales volume has reached $12.93 million, up from $7.43 million in April and $960,000 in January 2018, according to Securities and Exchange Commission-filed financials (http://ibn.fm/pXawe). The company’s performance…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered